ulcerative colitis

Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment
Ester Pagano, Joshua E Elias, Georg Schneditz, Svetlana Saveljeva, Lorraine M Holland, Francesca Borrelli, Tom H Karlsen, Arthur Kaser, Nicole C Kaneider

Gut Mar 2021, gutjnl-2020-323363; DOI: 10.1136/gutjnl-2020-323363
Drug development for ulcerative proctitis: current concepts
Bénédicte Caron, William J Sandborn, Stefan Schreiber, Remo Panaccione, Silvio Danese, Laurent Peyrin-Biroulet

Gut Mar 2021, gutjnl-2021-324108; DOI: 10.1136/gutjnl-2021-324108
Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System
Nabeel Khan, Nadim Mahmud, Chinmay Trivedi, Walter Reinisch, James D Lewis

Gut Mar 2021, gutjnl-2021-324356; DOI: 10.1136/gutjnl-2021-324356
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
Corey A Siegel, Gil Y Melmed, Dermot PB McGovern, Victoria Rai, Florian Krammer, David T Rubin, Maria T Abreu, Marla C Dubinsky

Gut Apr 2021, 70 (4) 635-640; DOI: 10.1136/gutjnl-2020-324000
Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn’s disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource
Evangelos Stournaras, Wendi Qian, Apostolos Pappas, You Yi Hong, Rasha Shawky, UK IBD BioResource Investigators, Tim Raine, Miles Parkes

Gut Apr 2021, 70 (4) 677-686; DOI: 10.1136/gutjnl-2019-320185
Crohn’s disease instead of UC might increase the risk of small bowel cancer
Rui Zhao, Qian-Yi Wan, Yutao Wu, Yong Wang, Ya-Ping Cui, Xiaoding Shen, Xiao Ting Wu

Gut Apr 2021, 70 (4) 809-810; DOI: 10.1136/gutjnl-2020-322201
Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?
Mohamed Attauabi, Jakob Seidelin, Johan Burisch

Gut Mar 2021, gutjnl-2021-324397; DOI: 10.1136/gutjnl-2021-324397
Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study
Adam G Clooney, Julia Eckenberger, Emilio Laserna-Mendieta, Kathryn A Sexton, Matthew T Bernstein, Kathy Vagianos, Michael Sargent, Feargal J Ryan, Carthage Moran, Donal Sheehan, Roy D Sleator, Laura E Targownik, Charles N Bernstein, Fergus Shanahan, Marcus J Claesson

Gut Mar 2021, 70 (3) 499-510; DOI: 10.1136/gutjnl-2020-321106
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies
Thomas X Lu, Matthew Dapas, Erika Lin, Trevor Peters, Atsushi Sakuraba

Gut Dec 2020, gutjnl-2020-321609; DOI: 10.1136/gutjnl-2020-321609
Synbindin restrains proinflammatory macrophage activation against microbiota and mucosal inflammation during colitis
Luoyan Ai, Yimeng Ren, Mingming Zhu, Shiyuan Lu, Yun Qian, Zhaofei Chen, Antao Xu

Gut Jan 2021, gutjnl-2020-321094; DOI: 10.1136/gutjnl-2020-321094

Main menu

ulcerative colitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

ulcerative colitis

Pages